Fjarde Ap Fonden Merck & Co., Inc. Transaction History

Fjarde Ap Fonden

$9.04 Billion
Q1 2024

A detailed history of Fjarde Ap Fonden transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 711,629 shares of MRK stock, worth $88.1 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares

711,629

Previous 689,533 3.2%

Holding current value

$88.1 Million

Previous $75.2 Million 24.91%

% of portfolio

1.04%

Previous 0.94%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$113.24 - $131.95 $2.5 Million - $2.92 Million	22,096 Added 3.2%	711,629 $93.9 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $15.2 Million - $16.5 Million	-151,497 Reduced 18.01%	689,533 $75.2 Million
Q3 2023 Oct 23, 2023	SELL	$102.95 - $114.33 $1.7 Million - $1.89 Million	-16,500 Reduced 1.92%	841,030 $86.6 Million
Q2 2023 Aug 02, 2023	BUY	$108.61 - $118.38 $4.51 Million - $4.91 Million	41,500 Added 5.09%	857,530 $99 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $1.74 Million - $1.94 Million	-16,900 Reduced 2.03%	816,030 $86.8 Million

Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $4.83 Million - $6.19 Million	-55,219 Reduced 6.22%	832,930 $92.4 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $20.9 Million - $23.7 Million	250,400 Added 39.26%	888,149 $81 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $1.21 Million - $1.35 Million	-16,427 Reduced 2.51%	637,749 $52.3 Million
Q4 2021 Feb 15, 2022	SELL	$72.28 - $90.54 $2.41 Million - $3.02 Million	-33,400 Reduced 4.86%	654,176 $50.1 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $1.18 Million - $1.3 Million	-16,433 Reduced 2.33%	687,576 $51.6 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $3.29 Million - $3.64 Million	-46,800 Reduced 6.23%	704,009 $54.8 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $227,238 - $267,663	3,300 Added 0.44%	750,809 $57.9 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $1.64 Million - $1.82 Million	-22,800 Reduced 2.96%	747,509 $61.1 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $2.21 Million - $2.51 Million	30,200 Added 4.08%	770,309 $63.9 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $2.8 Million - $3.18 Million	39,700 Added 5.67%	740,109 $57.2 Million
Q1 2020 May 11, 2020	SELL	$63.36 - $87.82 $1.92 Million - $2.66 Million	-30,300 Reduced 4.15%	700,409 $53.9 Million
Q4 2019 Feb 10, 2020	SELL	$77.58 - $87.54 $116,370 - $131,310	-1,500 Reduced 0.2%	730,709 $66.5 Million
Q3 2019 Oct 31, 2019	SELL	$76.08 - $82.93 $1.84 Million - $2.01 Million	-24,223 Reduced 3.2%	732,209 $61.6 Million
Q2 2019 Jul 17, 2019	SELL	$69.84 - $81.59 $2.07 Million - $2.42 Million	-29,600 Reduced 3.77%	756,432 $63.4 Million
Q1 2019 Apr 29, 2019	BUY	$69.58 - $79.36 $10.7 Million - $12.2 Million	154,225 Added 24.41%	786,032 $65.4 Million
Q4 2018 Jan 31, 2019	SELL	$65.24 - $75.71 $5.36 Million - $6.22 Million	-82,100 Reduced 11.5%	631,807 $48.3 Million
Q3 2018 Nov 09, 2018	SELL	$57.69 - $67.84 $2 Million - $2.35 Million	-34,668 Reduced 4.63%	713,907 $50.6 Million
Q2 2018 Jul 12, 2018	SELL	$50.83 - $59.72 $1.24 Million - $1.45 Million	-24,319 Reduced 3.15%	748,575 $45.4 Million
Q1 2018 May 07, 2018	BUY	$50.96 - $59.23 $379,550 - $441,145	7,448 Added 0.97%	772,894 $42.1 Million
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $6.11 Million - $7.3 Million	118,354 Added 18.29%	765,446 $43.1 Million
Q3 2017 Nov 07, 2017	BUY	$58.67 - $63.13 $493,180 - $530,670	8,406 Added 1.32%	647,092 $41.4 Million
Q2 2017 Aug 08, 2017	BUY	N/A	638,686	638,686 $40.9 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account